Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about FOXP3: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
FOXP3 is a gene implicated in neurodegeneration research. Key relationships include: regulates, associated with, activates. Associated with ALS, Aging, Als. Connected to 281 entities in the SciDEX knowledge graph.
No AI portrait yet
| Gene Symbol | FOXP3 |
| Full Name | FOXP3 (Forkhead Box P3) |
| Chromosome | Xp11.23 |
| Protein Type | Transcription Factor |
| Target Class | Transcription Factor |
| Function | Transcription factor modulation - no direct small molecule binding |
| Mechanism of Action | Transcription factor modulation - no direct small molecule binding |
| Druggability | Low (0.35) |
| Clinical Stage | Phase I |
| Amino Acids | 431 aa |
| Pathways | Apoptosis, Complement, Hedgehog, Immune Response, Mtor |
| UniProt ID | A0A494BZV0 |
| GeneCards | FOXP3 |
| Human Protein Atlas | FOXP3 |
| Associated Diseases | Als, Alzheimer, Autoimmune, cancer |
| Known Drugs/Compounds | paeoniflorin, Paeoniflorin |
| Interactions | ACHE, ACOD1, AIF1, AKT, AMPK, AND |
| SciDEX Target | View Target Profile (2 clinical trials) |
| KG Connections | 590 knowledge graph edges |
| Databases | GeneCardsNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
FOXP3["FOXP3"] -->|"co discussed"| TNFA["TNFA"]
FOXP3["FOXP3"] -->|"co discussed"| PPARGC1A["PPARGC1A"]
FOXP3["FOXP3"] -->|"co discussed"| PRKAA1["PRKAA1"]
FOXP3["FOXP3"] -->|"co discussed"| NR3C1["NR3C1"]
FOXP3["FOXP3"] -->|"co discussed"| DRD2["DRD2"]
FOXP3["FOXP3"] -->|"co discussed"| CHR2["CHR2"]
TGFB1["TGFB1"] -->|"interacts"| FOXP3["FOXP3"]
style FOXP3 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Regulatory T cells | expressed_in | cell_type | 0.95 |
| CD4(+) T Cells | expressed_in | cell_type | 0.95 |
| Regulatory T Cell Differentiation | regulates | process | 0.95 |
| Regulatory T Cell | expressed_in | cell_type | 0.95 |
| macrophage phagocytosis | promotes | process | 0.95 |
| acute ischemic stroke | protects_against | disease | 0.92 |
| cargo metabolism | enhances | process | 0.90 |
| macrophage phagocytosis | enhances | process | 0.90 |
| cargo metabolism | regulates | process | 0.90 |
| immune_tolerance | maintains | phenotype | 0.90 |
| acute ischemic stroke | therapeutic_target | disease | 0.87 |
| cargo metabolism | promotes | process | 0.87 |
| Inflammation | activates | disease | 0.85 |
| Inflammation | regulates | disease | 0.85 |
| paeoniflorin | interacts_with | compound | 0.85 |
| immune response suppression | mediates | process | 0.85 |
| Als | activates | disease | 0.85 |
| Macrophage phagocytosis | facilitates | process | 0.80 |
| Als | inhibits | disease | 0.75 |
| NOTCH | activates | gene | 0.70 |
| STING | inhibits | gene | 0.70 |
| SQSTM1 | activates | gene | 0.70 |
| NLRP3 | activates | gene | 0.70 |
| PYCARD | activates | gene | 0.70 |
| OPTN | activates | gene | 0.70 |
| GSK3B | interacts_with | gene | 0.70 |
| STING | markers | gene | 0.70 |
| LRRK2 | activates | gene | 0.70 |
| XIAP | activates | gene | 0.70 |
| IBA1 | activates | gene | 0.70 |
| MACROPHAGE | expresses | cell_type | 0.70 |
| OLIGODENDROCYTE | activates | cell_type | 0.70 |
| LAMP1 | interacts_with | gene | 0.70 |
| ULK1 | activates | gene | 0.70 |
| STING | activates | gene | 0.70 |
| Immune Response | activates | pathway | 0.70 |
| IL-6 | activates | gene | 0.70 |
| neural stem cells | expressed_in | cell_type | 0.70 |
| INFLAMMATION | regulates | gene | 0.70 |
| CD4 | activates | gene | 0.70 |
| GENES | inhibits | gene | 0.70 |
| CD4 | regulates | gene | 0.70 |
| Tumor | activates | disease | 0.65 |
| Ms | activates | disease | 0.65 |
| Carcinoma | expressed_in | disease | 0.65 |
| MTOR | activates | gene | 0.65 |
| Neuroinflammation | inhibits | disease | 0.65 |
| Cancer | therapeutic_target | disease | 0.65 |
| Multiple Sclerosis | activates | disease | 0.65 |
| Cancer | activates | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| h-6a065252 | targets_gene | hypothesis | 0.90 |
| macroautophagy | modulates | process | 0.85 |
| macroautophagy | regulates | process | 0.85 |
| LC3 | regulates | entity | 0.85 |
| Paeoniflorin | binds | compound | 0.85 |
| macroautophagy | inhibits | process | 0.82 |
| h-6a065252 | targets | hypothesis | 0.80 |
| CD38 | regulates | gene | 0.70 |
| CCL2 | regulates | gene | 0.70 |
| CX3CR1 | regulates | gene | 0.70 |
| CGAS | interacts_with | gene | 0.70 |
| BECN1 | interacts_with | gene | 0.70 |
| AMPK | activates | gene | 0.70 |
| CCL2 | expresses | gene | 0.70 |
| BECN1 | activates | gene | 0.70 |
| ACHE | activates | gene | 0.70 |
| AIF1 | activates | gene | 0.70 |
| CD4 | activates | gene | 0.70 |
| INFLAMMATION | regulates | gene | 0.70 |
| STAT3 | regulates | gene | 0.60 |
| MAP2K2 | expressed_in | gene | 0.60 |
| ATM | expressed_in | gene | 0.60 |
| SYT1 | regulates | gene | 0.60 |
| CX3CR1 | associated_with | gene | 0.60 |
| HMOX1 | regulates | gene | 0.60 |
| AKT | inhibits | gene | 0.60 |
| SYP | regulates | gene | 0.60 |
| CD8 | expressed_in | gene | 0.60 |
| ACSL4 | associated_with | gene | 0.60 |
| RELA | regulates | gene | 0.60 |
| MMP9 | activates | gene | 0.60 |
| CD4 | therapeutic_target | gene | 0.60 |
| JUN | regulates | gene | 0.60 |
| RORC | activates | gene | 0.60 |
| CD4 | regulates | gene | 0.60 |
| RORA | associated_with | gene | 0.60 |
| BMP7 | associated_with | gene | 0.60 |
| CD4 | inhibits | gene | 0.60 |
| AHR | associated_with | gene | 0.60 |
| EP300 | associated_with | gene | 0.60 |
| JUN | associated_with | gene | 0.60 |
| CD14 | regulates | gene | 0.60 |
| P2RX3 | regulates | gene | 0.60 |
| NLRP3 | activates | gene | 0.60 |
| CD38 | associated_with | gene | 0.60 |
| BAX | activates | gene | 0.60 |
| VIMENTIN | activates | gene | 0.60 |
| GATA3 | activates | gene | 0.60 |
| TLR4 | activates | gene | 0.60 |
| P2RY2 | regulates | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
neurodegeneration | 2026-04-11 | 0 hypotheses
neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.756
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity